azacitidine has been researched along with Fragile X Syndrome in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiurazzi, P; Tabolacci, E | 1 |
Kumari, D; Usdin, K | 1 |
Nielsen, AL; Sølvsten, C | 1 |
Bar-Nur, O; Benvenisty, N; Caspi, I | 1 |
Chiurazzi, P; Neri, G; Oostra, B; Pietrobono, R; Pomponi, MG; Tabolacci, E | 1 |
Ceman, S; Coffee, B; Reines, D; Warren, ST; Zhang, F | 1 |
Chiurazzi, P; Moscato, U; Neri, G; Oostra, BA; Pietrobono, R; Tabolacci, E | 1 |
Biacsi, R; Kumari, D; Usdin, K | 1 |
Dev, VG; Mixon, JC | 1 |
Coffee, B; Reines, D; Warren, ST; Zhang, F | 1 |
Bakker, CE; Chiurazzi, P; Neri, G; Oostra, BA; Pietrobono, R; Pomponi, MG | 1 |
Berger, C; Coyle-Morris, J; Gemmill, RM; Glover, TW; Pearce-Birge, L | 1 |
1 review(s) available for azacitidine and Fragile X Syndrome
Article | Year |
---|---|
Epigenetics, fragile X syndrome and transcriptional therapy.
Topics: Animals; Azacitidine; Chromatin Assembly and Disassembly; DNA Methylation; Epigenesis, Genetic; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histones; Humans; RNA; Transcription, Genetic | 2013 |
11 other study(ies) available for azacitidine and Fragile X Syndrome
Article | Year |
---|---|
Polycomb group complexes are recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription.
Topics: Alleles; Azacitidine; Cell Line; Decitabine; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Histones; Humans; Lymphocytes; Male; Naphthalenes; Polycomb Repressive Complex 2; Pyrones; RNA, Messenger; RNA, Small Interfering; Sirtuin 1; Transcription, Genetic | 2014 |
FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Topics: 5' Untranslated Regions; Azacitidine; Base Sequence; Decitabine; DNA Primers; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Gene Silencing; Genes, Reporter; HEK293 Cells; Humans; Male; Mutation; RNA, Messenger; Transfection; Trinucleotide Repeat Expansion; Trinucleotide Repeats | 2011 |
Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Differentiation; Cells, Cultured; Chromatin Assembly and Disassembly; Epigenesis, Genetic; Fragile X Mental Retardation Protein; Fragile X Syndrome; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Induced Pluripotent Stem Cells; Mice; Neurons | 2012 |
Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.
Topics: Azacitidine; Base Sequence; Cell Line; CpG Islands; Decitabine; DNA; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Male; Molecular Sequence Data; Nerve Tissue Proteins; Promoter Regions, Genetic; RNA-Binding Proteins; RNA, Messenger; Sequence Analysis, DNA | 2002 |
Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome.
Topics: Acetylation; Alleles; Azacitidine; Decitabine; DNA Methylation; Fragile X Mental Retardation Protein; Fragile X Syndrome; Heterochromatin; Histones; Humans; Lysine; Nerve Tissue Proteins; RNA-Binding Proteins; Transcriptional Activation; Trinucleotide Repeats; Tumor Cells, Cultured | 2002 |
Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.
Topics: Acetylation; Acetylcarnitine; Azacitidine; Cell Line; Chromatin Immunoprecipitation; Decitabine; DNA Methylation; Epigenesis, Genetic; Exons; Fragile X Mental Retardation Protein; Fragile X Syndrome; Histones; Humans; Male; Nerve Tissue Proteins; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA-Binding Proteins | 2005 |
SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome.
Topics: Alleles; Azacitidine; Base Sequence; Cell Line; Decitabine; DNA Methylation; DNA Primers; Enzyme Inhibitors; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Silencing; Histones; Humans; Hydroxamic Acids; Models, Biological; Mutation; Naphthalenes; Niacinamide; Promoter Regions, Genetic; Pyrones; Sirtuin 1; Sirtuins; Trinucleotide Repeat Expansion | 2008 |
Fragile X expression is decreased by 5-azacytidine and S-adenosylhomocysteine.
Topics: Azacitidine; Cell Line; Culture Media; DNA; Dose-Response Relationship, Drug; Floxuridine; Fragile X Syndrome; Homocysteine; Humans; Karyotyping; Methionine; Methylation; S-Adenosylhomocysteine; S-Adenosylmethionine; Sex Chromosome Aberrations | 1983 |
Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.
Topics: Acetylation; Acetyltransferases; Azacitidine; Cells, Cultured; Chromatin; Decitabine; DNA; Enzyme Inhibitors; Fragile X Mental Retardation Protein; Fragile X Syndrome; Histone Acetyltransferases; Histones; Humans; Hydroxamic Acids; Male; Nerve Tissue Proteins; Protein Binding; RNA-Binding Proteins; Saccharomyces cerevisiae Proteins; Transcription, Genetic | 1999 |
Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene.
Topics: Acetylation; Azacitidine; Base Sequence; Cell Line; Decitabine; DNA Methylation; DNA Primers; Enzyme Inhibitors; Fragile X Mental Retardation Protein; Fragile X Syndrome; Histone Deacetylase Inhibitors; Histones; Humans; Male; Nerve Tissue Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins | 1999 |
DNA demethylation induced by 5-azacytidine does not affect fragile X expression.
Topics: Azacitidine; Cell Line; Chromosome Fragility; DNA; DNA Restriction Enzymes; Fragile X Syndrome; Gene Expression Regulation; Genetic Markers; Humans; Lymphocytes; Male; Methylation; X Chromosome | 1986 |